Posts Feed
Comments Feed

Archive for the 'Colorectal Cancer' Category

Advanced Metastatic Colorectal Cancer - FUSILEV? Receives Unique, Product-Specific J-Code From The CMS, USA

Nov 21st 2008Drug InformationColorectal Cancer

Spectrum Pharmaceuticals, Inc., (NasdaqGM:SPPI) announced today that the Centers for Medicare and Medicaid Services (CMS), under the Medicare Part B benefit, has assigned a unique, product-specific billing code, or J-code, for FUSILEV? (levoleucovorin). FUSILEV? is the only commercially available formulation comprised only of the pharmacologically active isomer of leucovorin.

More: continued here

No Comments »

Messages Of Hope Work Better In Motivating Black Patients To Seek Early Screening For Cancer

Nov 21st 2008Drug InformationColorectal Cancer

News articles that stress African-American health disparities, like higher cancer mortality rates than other groups, may discourage black patients from being screened for cancer, according to a Saint Louis University study. Instead, they are more likely to be tested for cancer after hearing positive messages that emphasize progress made among African-American cancer patients.

More: continued here

No Comments »

Plymouth Hospitals To Lead Cancer Surgery Training Programme, England

Nov 21st 2008Drug InformationColorectal Cancer

Plymouth Hospitals NHS Trust has been chosen to co-ordinate the national programme for the training of existing consultants in advanced keyhole surgery for the treatment of bowel cancer. The Department of Health has appointed Consultant General Surgeon, Mr Mark Coleman as the National Clinical Lead for the Laparoscopic Colorectal Cancer Surgery Training Programme.

More: continued here

No Comments »

« Prev - Next »

1